Analyst consensus rating
Satellos Bioscience Analyst Rating: Strong Buy
Direct answer
Satellos Bioscience's consensus rating is Strong Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $24.17.
Forecast evidence checked October 17, 2026.
Get free Satellos Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.46
- Average price target
- $24.17
- High price target
- $40.00
- Low price target
- $16.00
- Low target gap
- +147.7%
- Target upside
- +274.1%
- High target gap
- +519.2%
- Target range width
- 371.5%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Satellos Bioscience?
Satellos Bioscience has a verified Strong Buy consensus. The same dataset has an average price target of $24.17.
How far are Satellos Bioscience's low and high targets from the recorded price?
The low target implies +147.7%, while the high target implies +519.2%.
How many analysts are included in Satellos Bioscience's consensus?
The verified consensus includes 6 analysts.
How is Satellos Bioscience's target upside or downside calculated?
The average target of $24.17 is divided by the recorded price of $6.46, then one is subtracted to produce +274.1%. This does not guarantee a future return.
When was Satellos Bioscience's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.